openPR Logo
Press release

Honorvets365 Launches New Apparel Brand Dedicated to Honoring American Veterans

09-28-2024 12:18 AM CET | Fashion, Lifestyle, Trends

Press release from: ABNewswire

Honorvets365 Launches New Apparel Brand Dedicated to Honoring

New brand offers a portion of proceeds to Veteran charities.
Honorvets365.com [https://www.honorvets365.com/] is proud to announce the official launch of its new brand, designed to honor and support American veterans. The brand offers a wide range of high-quality, fashionable apparel and accessories for men and women, with a portion of every sale going directly to veteran charities. This initiative allows customers to express their gratitude for those who have served while making a tangible impact on veterans' lives.

The mission behind Honorvets365 is simple: to provide top-notch fashion that carries the message of resilience, honor, and respect for veterans. Every item is crafted from world-class materials to ensure both style and comfort, offering everything from casual wear to more patriotic designs aimed at celebrating the strength of those who have served in the military.

Supporting Veterans with Every Purchase

Honorvets365 takes pride in its unique business model, which goes beyond just offering quality clothing. A portion of the proceeds from every sale is donated to various veteran organizations and programs, helping to fund unemployment assistance and other vital services for veterans in need.

Kirsten Stevens, a representative of Honorvets365, shared her thoughts on the brand's goals: "At Honorvets365, we aim to not only offer exceptional clothing but also to create a lasting impact on the lives of our nation's veterans. Every purchase helps us provide the necessary support to veterans who have given so much for our country."

Patriotic Designs for a Purpose

The brand's apparel features patriotic designs that are both stylish and meaningful, inspiring customers to wear their support for veterans with pride. From t-shirts to accessories, Honorvets365's collection appeals to both men and women who want to make a difference while dressing with purpose. Customers can take advantage of special promotions, including up to 50% off select items for a limited time, further extending the opportunity to support the veteran community.

For more information about the brand and to explore the full collection, visit www.Honorvets365.com [http://www.Honorvets365.com/].

About Honorvets365

Honorvets365 was founded with the goal of honoring veterans through fashion. By offering high-quality apparel and donating a portion of every purchase to veteran charities, the brand seeks to create a meaningful connection between customers and the veterans they wish to support.

Media Contact
Company Name: Honorvets365
Contact Person: JB
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=honorvets365-launches-new-apparel-brand-dedicated-to-honoring-american-veterans]
Country: United States
Website: https://www.honorvets365.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Honorvets365 Launches New Apparel Brand Dedicated to Honoring American Veterans here

News-ID: 3671243 • Views:

More Releases from ABNewswire

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our
Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Retinal Vein Occlusion Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape. It covers the Retinal Vein Occlusion pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Retinal Vein Occlusion pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore

All 5 Releases